Abstract
In this study, the relation between osteoporosis and vitamin D and the disease activity in patients with ankylosing spondylitis (AS) was investigated. A hundred patients with AS and 58 healthy individuals were included in the study. In addition to the routine blood and urine tests, serum 25-(OH)D3, parathormone (PTH), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), total calcium, ionized calcium, and phosphorous levels of all participants were also measured. Bone mineral density (BMD) measurements were performed at the anterior–posterior and lateral lumbar and femur regions. Anterior–posterior and lateral thoracic and lumbosacral radiography was performed on all participants. The disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), functional status by Bath Ankylosing Spondylitis Functional Index (BASFI), and mobility by Bath Ankylosing Spondylitis Metrology Index (BASMI). In the patient group, BMD values obtained from the lateral lumbar and femur regions and serum vitamin D levels were lower than the control group. A negative relation was determined between the lateral lumbar BMD values and ESR, CRP, and BASDAI scores of patients with AS. The ESR, CRP levels, and BASMI scores of the AS patients with osteoporosis were significantly higher, when compared to patients without osteoporosis. The negative correlation between serum 25-(OH)D3 level and ESR, CRP levels did not reach a statistically significant level in patients with AS; the positive correlation between PTH levels and ESR, and the negative correlation between CRP and BASDAI also did not reach a statistically significant level. Vitamin D deficiency in AS may indirectly lead to osteoporosis by causing an increase in the inflammatory activity. The present authors believe that it would be beneficial to monitorize vitamin D levels together with BMD measurements in order to determine the patients under osteoporosis risk.
Similar content being viewed by others
References
Van Der Linden S, Van Der Hejide D, Braun J (2005) Ankylosing spondylitis. In: Harris ED, Budd RC, Frestein GS et al (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, Philadelphia, PA, pp 1125–1141
Will R, Palmer R, Bhalla AK et al (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2(8678–8679):1483–1485
Gratacos J, Collado A, Pons F et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42(11):2319–2324
Lange U, Teichmann J, Strunk J et al (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004
Lange U, Jung O, Teichmann J et al (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12(12):1031–1035
Manolagas SC (1995) Role of cytokines in bone resorption. Bone 17(2 Suppl):63S–67S
Pacifici R (1995) Cytokines and osteoclast activity. Calcif Tissue Int 56(Suppl 1):S27–S28
Nguyen L, Dewhirst FE, Hauschka PV et al (1991) Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10(1–2):15–21
Fujita T, Matsui T, Nakao Y et al (1990) Cytokines and osteoporosis. Ann N Y Acad Sci 587:371–375
Baier R, Grauer A, Lazaretti-Castro M et al (1994) Differential effects of 1, 25-dihydroxyvitamin D3 on cell proliferation and calcitonin gene expression. Endocrinology 135(5):2006–2011
Muller K, Bendtzen K (1996) 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J Investig Dermatol Symp Proc 1(1):68–71
Amento EP (1987) Vitamin D and the immune system. Steroids 49(1–3):55–72
Bouillon R, Okamura WH, Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16(2):200–257
Cantorna MT, Mahon BD (2005) D-hormone and the immune system. J Rheumatol Suppl 76:11–20
Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. Faseb J 15(14):2579–2585
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
Yanik B, Gursel YK, Kutlay S et al (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24(1):41–47
Ay S, Kutlay Ş, Kurtaiş Y (2004) Ankilozan Spondilitli Hastalarda Bath Ankilozan Spondilit Hastalık Aktivite İndeksinin (BASHAİ) Türkçe Versiyonunun Geçerlilik Ve Güvenirlik Çalışması. Romatizma (Acta Rheumatol Turcica) 19(3):139–146
Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694–1698
Melton LJIII, Lane AW, Cooper C et al (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3(3):113–119
Ozoran K, Paker N, Basgoze O et al (1989) Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density. J Int Med Res 17(4):395–400
El Maghraoui A, Borderie D, Cherruau B et al (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26(10):2205–2209
Ralston SH, Urquhart GD, Brzeski M et al (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300(6724):563–565
Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76(4):660–665
Lange U, Kluge A, Strunk J et al (2005) Ankylosing spondylitis and bone mineral density—what is the ideal tool for measurement? Rheumatol Int 26(2):115–120
Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Relat Res 74:59–64
Cooper C, Carbone L, Michet CJ et al (1994) Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21(10):1877–1882
Donnelly S, Doyle DV, Denton A et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53(2):117–121
Gratacos J, Collado A, Filella X et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33(10):927–931
El Maghraoui A (2004) Osteoporosis and ankylosing spondylitis. Joint Bone Spine 71(4):291–295
Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18(5):364–368
Franck H, Meurer T, Hofbauer LC (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31(11):2236–2241
Saino H, Matsuyama T, Takada J et al (1997) Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats. J Bone Miner Res 12(11):1844–1850
Jiang Y, Zhao J, Genant HK et al (1998) Bone mineral density and biomechanical properties of spine and femur of ovariectomized rats treated with naproxen. Bone 22(5):509–514
Devogelaer JP, Maldague B, Malghem J, Nagant de Deuxchaisnes C (1992) Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 35(9):1062–1067
Reid DM, Nicoll JJ, Kennedy NS et al (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13(5):932–935
Masud T, Langley S, Wiltshire P et al (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307(6897):172–173
Bronson WD, Walker SE, Hillman LS et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25(5):929–935
Gilgil E, Kacar C, Tuncer T et al (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32(2):292–294
Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 29(7):1511–1519
Selby P (2008) Rickets and osteomalacia. In: Hochberg MC (ed) Rheumatology. Mosby Elsevier, Amsterdam, pp 1977–1987
Conflict of interest
There is no conflict of interest regarding financial or other relationships.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mermerci Başkan, B., Pekin Doğan, Y., Sivas, F. et al. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30, 375–381 (2010). https://doi.org/10.1007/s00296-009-0975-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0975-7